Voltar para publicações

A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial

  • Artigo
2020
Compartilhe

American Heart Journal, vol. 231

Doi: 10.1016/j.ahj.2020.10.001

Voltar para publicações